Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust Provides $9.4M to Make Galapagos Predictive Drug Data Public

NEW YORK (GenomeWeb News) – A grant and license agreement involving the UK’s Wellcome Trust, the Belgian company Galapagos, and the European Molecular Biology Laboratory's European Bioinformatics Institute will open up the rights to databases held by Galapagos division BioFocus DPI for use by public research communities.
 
EMBL-EBI will use a Wellcome Trust grant of £4.7 million ($9.4 million) to support the transfer of a collection of information on drug properties and a set of Galapagos’ drug-like small molecules to the Institute. EMBL-EBI will incorporate the data into its collection of open-access resources for use in biomedical research.
 
Galapagos will receive £1.4 million for the data, which it previously offered for license through its BioFocus DPI service division.
 
The Galapagos databases covered under the agreement are DrugStore, StARLITe, Strudle, Kinase SARfari, and GPCR SARfari.
 
The agreement does not include the StarDrop software platform, which BioFocus DPI will continue to offer.
 
"The scientific community worldwide will greatly benefit from the access to these data for aiding predictive drug discovery," Galapagos CEO Onno van de Stolpe said in a statement.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.